雌激素替代疗法
Estrogen replacement therapy.
作者信息
Higgin J R
出版信息
Can Fam Physician. 1989 Jun;35:1375-7.
Abstract
The present status of estrogen replacement therapy suggests that its benefits far outweigh the risks; it is hoped that the incapacity related to fractures, coronary artery disease, and urinary incontinence may be reduced or prevented. Estrogen replacement therapy should provide for a healthier elderly population, increase the number who can remain in their homes, and therefore reduce the number that require institutionalization.
摘要
雌激素替代疗法的现状表明，其益处远大于风险；人们希望与骨折、冠状动脉疾病和尿失禁相关的功能丧失情况能够减少或预防。雌激素替代疗法应为更健康的老年人群提供保障，增加能够居家养老的人数，从而减少需要机构照料的人数。
相似文献
1
Estrogen replacement therapy.雌激素替代疗法
Can Fam Physician. 1989 Jun;35:1375-7.
2
Relative risks and benefits of long-term estrogen replacement therapy: a decision analysis.长期雌激素替代疗法的相对风险与益处：一项决策分析。
Obstet Gynecol. 1994 Feb;83(2):161-6.
3
What is the available evidence for hormone replacement therapy in women with stress urinary incontinence?压力性尿失禁女性激素替代疗法的现有证据有哪些？
J Obstet Gynaecol Can. 2003 Jul;25(7):567-74. doi: 10.1016/s1701-2163(16)31015-5.
4
The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women.绝经后女性冠心病的流行病学与雌激素替代疗法
Prog Cardiovasc Dis. 1995 Nov-Dec;38(3):199-210. doi: 10.1016/s0033-0620(95)80012-3.
5
Estrogen replacement therapy at menopause. How benefits outweigh risks.更年期雌激素替代疗法。益处如何大于风险。
Postgrad Med. 1994 Oct;96(5):131-40.
6
Evaluating the benefits and risks of postmenopausal hormone therapy.评估绝经后激素治疗的益处与风险。
Am J Med. 1991 Nov 25;91(5B):14S-18S. doi: 10.1016/0002-9343(91)90241-o.
7
Who Should Receive Hormone Replacement Therapy?谁应该接受激素替代疗法？
J Thromb Thrombolysis. 1996;3(1):13-21. doi: 10.1007/BF00226405.
8
[Estrogens for prevention of coronary heart disease?].雌激素用于预防冠心病？
Herz. 1997 Jun;22(3):151-7. doi: 10.1007/BF03044352.
9
Estrogen replacement therapy in the elderly.老年人的雌激素替代疗法。
Zentralbl Gynakol. 1996;118(5):255-61.
10
Estrogen-replacement therapy after breast cancer. Risks versus benefits.乳腺癌后的雌激素替代疗法。风险与益处。
Cancer. 1993 Mar 15;71(6 Suppl):2169-76. doi: 10.1002/1097-0142(19930315)71:6+<2169::aid-cncr2820711608>3.0.co;2-b.
本文引用的文献
1
Objective techniques for the assessment of postmenopausal hot flashes.评估绝经后潮热的客观技术。
Obstet Gynecol. 1981 Mar;57(3):340-4.
2
Estrogen levels in postmenopausal women with hot flashes.有潮热症状的绝经后女性的雌激素水平。
Obstet Gynecol. 1982 Apr;59(4):403-7.
3
The menopause: benefits and risks of estrogen-progestogen replacement therapy.更年期：雌激素 - 孕激素替代疗法的益处与风险
Fertil Steril. 1982 Apr;37(4):457-74. doi: 10.1016/s0015-0282(16)46149-2.
4
The effect of estrogen dose on postmenopausal bone loss.雌激素剂量对绝经后骨质流失的影响。
N Engl J Med. 1983 Dec 8;309(23):1405-7. doi: 10.1056/NEJM198312083092301.
5
Relative contributions of aging and estrogen deficiency to postmenopausal bone loss.衰老和雌激素缺乏对绝经后骨质流失的相对影响。
N Engl J Med. 1984 Nov 15;311(20):1273-5. doi: 10.1056/NEJM198411153112002.
6
Use of the progestogen challenge test to reduce the risk of endometrial cancer.使用孕激素激发试验以降低子宫内膜癌风险。
Obstet Gynecol. 1980 Jun;55(6):732-8.
7
Gonadotropins, estrogens, and adrenal steroids during the menopausal hot flash.绝经潮热期间的促性腺激素、雌激素和肾上腺类固醇。
J Clin Endocrinol Metab. 1980 Apr;50(4):685-9. doi: 10.1210/jcem-50-4-685.
8
The minimum effective dose of estrogen for prevention of postmenopausal bone loss.预防绝经后骨质流失的雌激素最小有效剂量。
Obstet Gynecol. 1984 Jun;63(6):759-63.
9
Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women.不同剂量经阴道给予结合马雌激素对绝经后女性的生物学效应。
J Clin Endocrinol Metab. 1983 Jul;57(1):133-9. doi: 10.1210/jcem-57-1-133.
10
Lipid and lipoprotein levels following pure estradiol implantation in post-menopausal women.
Gynecol Obstet Invest. 1985;19(4):207-12. doi: 10.1159/000299035.
Zotero 插件